Market Cap 15.84M
Revenue (ttm) 0.00
Net Income (ttm) -13.24M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 48,800
Avg Vol 52,640
Day's Range N/A - N/A
Shares Out 2.87M
Stochastic %K 5%
Beta 1.81
Analysts Strong Sell
Price Target $27.67

Company Profile

Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions. The company is developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-...

Industry: Biotechnology
Sector: Healthcare
Phone: 904 300 0701
Address:
822 A1A North, Suite 306, Ponte Vedra, United States
dark_orchid
dark_orchid May. 12 at 3:50 PM
0 · Reply
History101
History101 May. 12 at 1:33 AM
$CVKD not on my watchlist anymore, not until they can secure some funding.
0 · Reply
Joby099
Joby099 May. 12 at 1:15 AM
1 · Reply
Joby099
Joby099 May. 11 at 8:02 PM
0 · Reply
Hart4Charts
Hart4Charts May. 11 at 6:06 PM
0 · Reply
Joby099
Joby099 May. 11 at 3:49 PM
0 · Reply
Joby099
Joby099 May. 11 at 9:07 AM
0 · Reply
Joby099
Joby099 May. 10 at 9:52 PM
$MRAM $ALT $SUI $ASST $CVKD Looking forward to a great week! LFG! https://www.youtube.com/watch?v=E-qlgkuakRU
0 · Reply
mikesterz7
mikesterz7 May. 10 at 3:45 PM
$CVKD The company plans a randomized, blinded, placebo-controlled pivotal Phase 3 (~120 patients) to support a projected NDA submission in 2029.
1 · Reply
Investor203
Investor203 May. 10 at 2:58 PM
0 · Reply
Latest News on CVKD
Cadrenal Therapeutics Inc trading resumes

2026-04-01T19:35:16.000Z - 5 weeks ago

Cadrenal Therapeutics Inc trading resumes


Cadrenal Therapeutics highlights research on 12-LOX inhibition

2026-03-12T12:21:38.000Z - 2 months ago

Cadrenal Therapeutics highlights research on 12-LOX inhibition


Cadrenal Therapeutics announces Phase 2 results for CAD-1005

2026-02-24T13:39:32.000Z - 2 months ago

Cadrenal Therapeutics announces Phase 2 results for CAD-1005


Cadrenal's Quiet Expansion Play Is Starting to Get Loud

Dec 12, 2025, 11:00 AM EST - 5 months ago

Cadrenal's Quiet Expansion Play Is Starting to Get Loud


Cadrenal Therapeutics reports Q2 EPS ($1.87), consensus ($1.77)

2025-08-11T12:20:21.000Z - 9 months ago

Cadrenal Therapeutics reports Q2 EPS ($1.87), consensus ($1.77)


Cadrenal Therapeutics announces trial plans for tecarfarin

2025-08-05T10:25:11.000Z - 10 months ago

Cadrenal Therapeutics announces trial plans for tecarfarin


Cadrenal Therapeutics  teams with Abbott inTECH-LVAD trial

2025-03-04T13:21:36.000Z - 1 year ago

Cadrenal Therapeutics teams with Abbott inTECH-LVAD trial

ABT


dark_orchid
dark_orchid May. 12 at 3:50 PM
0 · Reply
History101
History101 May. 12 at 1:33 AM
$CVKD not on my watchlist anymore, not until they can secure some funding.
0 · Reply
Joby099
Joby099 May. 12 at 1:15 AM
1 · Reply
Joby099
Joby099 May. 11 at 8:02 PM
0 · Reply
Hart4Charts
Hart4Charts May. 11 at 6:06 PM
0 · Reply
Joby099
Joby099 May. 11 at 3:49 PM
0 · Reply
Joby099
Joby099 May. 11 at 9:07 AM
0 · Reply
Joby099
Joby099 May. 10 at 9:52 PM
$MRAM $ALT $SUI $ASST $CVKD Looking forward to a great week! LFG! https://www.youtube.com/watch?v=E-qlgkuakRU
0 · Reply
mikesterz7
mikesterz7 May. 10 at 3:45 PM
$CVKD The company plans a randomized, blinded, placebo-controlled pivotal Phase 3 (~120 patients) to support a projected NDA submission in 2029.
1 · Reply
Investor203
Investor203 May. 10 at 2:58 PM
0 · Reply
ZacksSCR
ZacksSCR May. 8 at 4:17 PM
$CVKD Designing Phase 3 Trial for CAD-1005 in HIT https://buff.ly/BXrJgse
0 · Reply
options1315
options1315 May. 8 at 2:19 AM
$CVKD scam. I knew it the first time all the scam bots started pumping this junk!!!!
0 · Reply
Monkey7779192
Monkey7779192 May. 8 at 12:17 AM
$CVKD Odd here. Being pumped by multiple account by a loser pr a scammer.
0 · Reply
focafoca99
focafoca99 May. 7 at 1:04 PM
$CVKD released its quarter ended March 31, 2026 financial results.
0 · Reply
Vaderesking
Vaderesking May. 6 at 12:55 PM
We Post Everyday, it's free, we do not sell anything, we do it to better our skillset. Keep us accountable. $SPY Test is complete, the run occurred and we are mid-week, every fiber of your body should be telling you to take profits and sit out the rest, and that would be the right thing to do. Conversely, watch 727.07, if we stay above continuation is on the table. $NQ Stuck in this zone, needs over 28514.25 or under 24822. $QQQ This 688.3 is key, we need to remain over it. Under I would expect a test of 683.08. $RTY 2872.2 test imminent here, I’m watching $CVKD, needs over $7.
0 · Reply
M00nM00
M00nM00 May. 6 at 10:15 AM
$CVKD Bots spamming boards is a sign of it being a
0 · Reply
DonVigo
DonVigo May. 6 at 9:31 AM
$CVKD $SNDK $DGXX Blocked 🚫
0 · Reply
RobbyAxelrod1
RobbyAxelrod1 May. 4 at 4:22 PM
$CVKD $SPY $GME $QQQ I thought i blocked you.
0 · Reply